Allison Dorval Insider Trading $VYGR Voyager Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Allison Dorval.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Allison Dorval. Allison Dorval is Chief Financial Officer in INSULET CORP ($PODD) and Chief Financial Officer in Voyager Therapeutics, Inc. ($VYGR).
Allison Dorval in Voyager Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Allison Dorval: Chief Financial Officer
Holdings: 109,894 shares
Current Value: $1,292,353
Latest Transaction: Mar 23 2021
$VYGR Market Capitalization: $316.10M
$VYGR Previous Close: $11.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Allison Dorval in Voyager Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 109,894 | 79.9 K to 109.9 K (+37.55 %) |
| Feb 18 2021 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Option Exercise | A | 7.33 | 68,000 | 498,440 | 68,000 | |
| Feb 18 2021 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Grant | A | 0.00 | 34,000 | 0 | 79,894 | 45.9 K to 79.9 K (+74.08 %) |
| Feb 16 2021 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Sell | S | 7.55 | 3,186 | 24,054 | 45,894 | 49.1 K to 45.9 K (-6.49 %) |
| Jan 14 2021 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Sell | S | 8.62 | 2,942 | 25,360 | 49,080 | 52 K to 49.1 K (-5.66 %) |
| Feb 12 2020 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Option Exercise | A | 12.96 | 55,000 | 712,800 | 55,000 | |
| Feb 12 2020 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Grant | A | 0.00 | 27,500 | 0 | 52,022 | 24.5 K to 52 K (+112.14 %) |
| Jan 29 2020 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Sell | S | 13.36 | 3,128 | 41,790 | 24,522 | 27.7 K to 24.5 K (-11.31 %) |
| Jan 17 2019 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Option Exercise | A | 9.10 | 50,000 | 455,000 | 50,000 | |
| Jan 17 2019 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 26,106 | 1.1 K to 26.1 K (+2,260.40 %) |
| Nov 09 2018 | VYGR | Voyager Therapeuti ... | Dorval Allison | Chief Financial Off ... | Option Exercise | A | 13.99 | 45,000 | 629,550 | 45,000 |
Page: 1